
"Additionally, HBOT exhibited favorable therapeutic effects in cases involving sensorineural hearing loss and acute macular neuroretinopathy secondary to rheumatic and autoimmune diseases. "
"Preclinical data demonstrate that HBOT enhances oxygen delivery to the inflamed myocardium, sup-presses the activation of NF-κB and NLRP3 inflammasomes, reduces oxidative stress, preserves mitochondrial function, and promotes immunoregulatory T-cell responses."
"Our data demonstrated that HBO2 therapy attenuated disease severity in NZB/W F1 mice. HBO2 treatment may be of use in the clinical treatment of lupus patients."
.jpg/:/cr=t:21.59%25,l:0%25,w:100%25,h:56.82%25/rs=w:515,h:234,cg:true)
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.